1. Board Resolution Date: June 16, 2026 2. Type and Amount of Dividend: Resolved to distribute a cash dividend of USD 3,000,000 for the 2025 fiscal year 3. Other Matters to be Disclosed: None
FACT BOX
- Source: PR Times
- Category: News
Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Jun 16, 2026 9:00 AM ・ Updated Jun 19, 2026 4:49 PM ・ 2 min read ・ Source: PR Times
Hin Hui Tianli (Hangzhou) Pharmaceutical Co., Ltd., a key subsidiary of Hin Hui, has resolved to distribute a cash dividend of USD 3 million for the 2025 fiscal year.
1. Board Resolution Date: June 16, 2026 2. Type and Amount of Dividend: Resolved to distribute a cash dividend of USD 3,000,000 for the 2025 fiscal year 3. Other Matters to be Disclosed: None
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.